相关实验视频

Updated: Sep 10, 2025

Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis

Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis

Published on: August 31, 2022

在膜纤维化中缓解和复发的预测因素

Milena Bond¹, Alessandra Bettiol², Eugenia Accorsi Buttini³

¹Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy.

Journal of internal medicine

|August 27, 2025

概括

鉴定了膜纤维化 (RPF) 缓解和复发的预测因素. 高预处理18F-FDG-PET活动预测缓解,而吸烟和非典型的RPF位置降低了缓解的机会. 胸部血管干扰和治疗后的18F-FDG-PET活动预测复发.

科学领域:

医学成像
癌症学
免疫学

背景情况:

逆肌纤维化 (RPF) 通常需要葡萄皮质类药物 (GC) 缓解,但复发很常见.
在RPF中缓解和复发的预测因素仍然不太清楚.
识别这些预测因素对于优化患者管理至关重要.

研究的目的:

确定RPF中的临床,实验室和成像预测因素.
在用GC治疗的RPF患者中确定复发的预测因子.

主要方法:

分析了使用GC治疗的115名RPF患者.
评估了基线和治疗后的成像 (CT,MRI,18F-FDG-PET).
用物流和考克斯回归模型分析缓解和复发时间的预测因素.

主要成果:

87. 8% 的患者实现了缓解;吸烟和非典型的 RPF 位置与较低的缓解率有关.
治疗前的18F-FDG-PET活动预测了良好的缓解 (OR 11.51).
42% 的患者复发;胸部血管卷入和阳性治疗结束18F-FDG-PET预测复发 (HR分别为2. 61和3. 47).

结论:

18F-FDG-PET代谢活动是RPF缓解和复发的关键预测因素.
吸烟和非典型的RPF局部化会对缓解产生负面影响.
胸前动脉受损与复发风险的增加有关.

关键词:

在IgG4 耳周炎定子发射断层扫描 (PET)膜纤维化血管炎

更多相关视频

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR

Published on: June 27, 2017

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

相关概念视频

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...